The Association Between Different Markers With Development of Maternal and Neonatal Complications in Women With Severe Preeclampsia

by palligoelme@gmail.com | Aug 15, 2025 | Clinical Trials

​ Conditions: Severe Preeclampsia Sponsors: Cairo University Completed Conditions: Severe Preeclampsia Sponsors: Cairo University Completed 

Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin

by palligoelme@gmail.com | Aug 15, 2025 | Clinical Trials

​ Conditions: Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Venous Thromboembolism (VTE); Prevention Interventions: Drug: Sodium enoxaparin; Drug: Dimolegin; Drug: Dimolegin placebo; Drug: Sodium enoxaparine placebo Sponsors: Avexima Diol LLC...

Pediatric Acute Respiratory Distress Syndrome (ARDS) Management Trial

by palligoelme@gmail.com | Aug 14, 2025 | Clinical Trials

​ Conditions: Acute Respiratory Distress Syndrome (ARDS); Ventilator Management; Lung-protective Ventilation; Pediatric Acute Respiratory Distress Syndrome (PARDS) Interventions: Other: High Driving Pressure Mechanical Ventilation; Other: Low Driving Pressure...

Studies on Adsorption International Learning Initiative Global

by palligoelme@gmail.com | Aug 14, 2025 | Clinical Trials

​ Conditions: CKD (Chronic Kidney Disease) Stage 5D; Uremia; Chronic; Uremic; Toxemia; Inflammation Chronic; Hemodialysis; Inflammation Biomarkers; Dialysis Related Complication; Anemia Associated With End Stage Renal Disease Interventions: Device: Patients will...

Safety & Efficacy of RenalGuard® Therapy in the Prevention of Cardiac Surgery Associated Acute Kidney Injury

by palligoelme@gmail.com | Aug 14, 2025 | Clinical Trials

​ Conditions: Cardiac Surgery Associated – Acute Kidney Injury; AKI – Acute Kidney Injury Interventions: Device: RenalGuard® Therapy; Other: Standard of Care (SOC) Sponsors: CardioRenal Systems, Inc.; University Malaysia Medical Centre; Institut Jantung...

Part B- G1X-CGD (Lentiviral Vector Transduced CD34+ Cells) in Patients With X-Linked Chronic Granulomatous Disease

by palligoelme@gmail.com | Aug 14, 2025 | Clinical Trials

​ Conditions: Chronic Granulomatous Disease (CGD) Interventions: Drug: Busulfan; Drug: Tocilizumab; Drug: Eltrombopag; Drug: Sirolimus; Other: pCCLChimGp91lentiviral vector containing the human gp91 phox (CYBB) gene Sponsors: National Institute of Allergy and...